Monument Therapeutics
PrivateLast Round
VC Round
Feb 25, 2025
Est. Valuation
$10.91M
Total Funding Raised
$4.31M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Monument Therapeutics is a biotechnology company that develops novel drugs for serious diseases of the central nervous system by using proprietary digital biomarkers to identify patients with homogenous underlying neurobiology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Monument Therapeutics Comparables
Compare Monument Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kynexis Therapeutics | 81% | |
| Alto Neuroscience | 78% | |
| AtaiBeckley Inc. | 77% | |
Monument Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 25, 2025 | ||||
| VC Round | Oct 15, 2024 | ||||
| VC Round | Apr 18, 2024 | ||||
| Seed | Dec 14, 2021 | ||||
| Seed | Jul 1, 2021 |
Monument Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | VC Round |
| Cambridge Angels | VC Round |
| o2h ventures | Seed, VC Round |
| Innovate UK | VC Round |
| Catapult Ventures | Seed |
| Neo Kuma Ventures | Seed |
| Wren Capital | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 92% MoM, reaching 3.2K.
- Jun 18, 2026
Monthly visitors grew 56% MoM, from 2.6K to 4K.
Monument Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Monument Therapeutics's valuation, stock price, and market status.